AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Basic Medicine | Publishing Language: Chinese | Open Access

Angiotensin Ⅱ type 1 receptor autoantibody-AT1R-Bmal1 axis promotes phenotypic transition of vascular smooth muscle cells and vascular fibrosis

Lingxia XUEYaolin LONGJiayan FENGTian MAOJiao GUOZhuoxi WANGYang LIXiaohui WANGLi WANG( )
School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi, China
Show Author Information

Abstract

Objective

To investigate the mechanism by which angiotensin Ⅱ type 1 receptor autoantibody (AT1-AA) promotes phenotypic switch of vascular smooth muscle cells (VSMCs) and vascular fibrosis through abnormal expression of circadian clock protein BMAL1.

Methods

Twelve male SD rats (6~8 weeks old, weighing 180~220 g) were randomly divided into (n=6) a control group and an AT1-AA-positive group [established by active immunization of SD rats with AT1R extracellular loop Ⅱ peptide (AT1R-ECL Ⅱ)]. HE and Masson stainings were used to observe structural changes and fibrosis in the thoracic aorta (n=3). Western blotting was performed to detect the expression of Collagen Ⅰ, phenotypic switch-related proteins (SM22, α-SMA, OPN and MMP2) in vascular tissues and primary VSMCs (n=4), as well as the expression of BMAL1 at CT0, CT4, CT8, CT12, CT16, and CT20. Transwell and scratch assays were used to assess the proliferation and migration of VSMCs (n=3). si-RNA was employed to knock down Bmal1, followed by detection of BMAL1, Collagen Ⅰ, and phenotypic conversion-related protein expression (n=3). Additionally, AT1-AA-positive AT1R-knockout (AT1R-KO) rats were constructed to measure BMAL1 expression in thoracic aortic tissues (n=4).

Results

The AT1-AA-positive rats had significantly thickened thoracic aortic vessel wall [(140±9)% vs (120±5)%, P<0.05], badly arranged VSMCs, obvious blue Masson staining, and up-regulated Collagen Ⅰ expression (P<0.05). In the thoracic aorta of AT1-AA-positive rats and AT1-AA-treated VSMCs, the expression of contractile phenotype-related proteins (α-SMA, SM22) was decreased (P<0.05), while the expression of synthetic phenotype-related proteins (OPN, MMP2) was increased (P<0.05). AT1-AA enhanced the scratch healing ability and migration ability of VSMCs. Furthermore, both mRNA and protein levels of Bmal1 were significantly up-regulated at CT12 (P<0.05), and the rhythmicity of Bmal1 was lost. Knockdown of Bmal1 partially ameliorated AT1-AA-induced phenotypic switch of VSMCs. Compared with AT1-AA-positive WT rats, AT1-AA-positive AT1R-KO rats showed significantly reduced BMAL1 expression in the thoracic aorta (1.35±0.06 vs 0.86±0.07, P<0.001). At the cellular level, AT1-AA-induced phenotypic switch and high Collagen Ⅰ expression in VSMCs were partially improved in AT1R-KO VSMCs.

Conclusion

AT1-AA promotes VSMCs phenotypic conversion and vascular fibrosis through the AT1R-Bmal1 axis.

CLC number: R322.12; R329.26; R392.11 Document code: A

References

【1】
【1】
 
 
Journal of Army Medical University
Pages 1155-1164

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
XUE L, LONG Y, FENG J, et al. Angiotensin Ⅱ type 1 receptor autoantibody-AT1R-Bmal1 axis promotes phenotypic transition of vascular smooth muscle cells and vascular fibrosis. Journal of Army Medical University, 2025, 47(11): 1155-1164. https://doi.org/10.16016/j.2097-0927.202412142

2

Views

0

Downloads

0

Crossref

0

Scopus

0

CSCD

Received: 29 December 2024
Revised: 23 March 2025
Published: 15 June 2025
© 2025 Journal of Army Medical University

This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/).